Azepan-1-yl(5-((2,4-dichlorophenoxy)methyl)furan-2-yl)methanone

Catalog No. :
ACGFCR210
CAS No. :
494852-40-3
Molecular Formula :
C18H19Cl2NO3
Molecular Weight :
368.26

IUPAC Name:azepan-1-yl(5-((2,4-dichlorophenoxy)methyl)furan-2-yl)methanone

Azepan-1-yl(5-((2,4-dichlorophenoxy)methyl)furan-2-yl)methanone structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$205.00Login to see priceIn stockInquiry
250mg98%$348.00Login to see priceIn stockInquiry
1g98%$936.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameAzepan-1-yl(5-((2,4-dichlorophenoxy)methyl)furan-2-yl)methanone
IUPAC Nameazepan-1-yl(5-((2,4-dichlorophenoxy)methyl)furan-2-yl)methanone
Molecular FormulaC18H19Cl2NO3
Molecular Weight368.26
SMILESO=C(C1=CC=C(COC2=CC=C(Cl)C=C2Cl)O1)N3CCCCCC3
InChI KeyKAKWSCYOEPHRJT-UHFFFAOYSA-N
SynonymWAY-325448;Methanone, [5-[(2,4-dichlorophenoxy)methyl]-2-furanyl](hexahydro-1H-azepin-1-yl)-;Azepan-1-yl(5-((2,4-dichlorophenoxy)methyl)furan-2-yl)methanone
CAS No.494852-40-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACGFCR210 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGFCR210 route product structure diagram
    ACGFCR210494852-40-3 In Stock
Inquiry

2. ACGFCR210 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGFCR210 route product structure diagram
    ACGFCR210494852-40-3 In Stock
Inquiry

Comments (0)